article · QJM
Abstract Background Cardiac affection in multisystem inflammatory syndrome in children (MIS-C) occurs in ∼80% of patients. Left ventricular (LV) systolic dysfunction is the most frequent finding. Methods In this prospective cohort study, we assessed LV function and cardiac injury in 22 patients with MIS-C using Cardiac biomarkers (Troponin I and CK-MB) and Speckle Tracking Echocardiography. We compare those patients at initial presentation and at 3 months follow up. Results Among the 22 patients with MIS-C cardiac biomarkers (cardiac troponin and CK-MB) showed statistically significant regression on comparing their values at initial presentation and after 10 days follow up (P value <0.01). Ejection fraction was impaired in 43.7%, with a mean value of 52.3% (Range: 32% to 69%). Patients with abnormal strain had a lower EF, more organ system involvement and were more likely to require inotropic support. Lower peak longitudinal strain rates were detected in 59% of MIS-C patients at initial presentation in comparison to follow up assessment 3 months later. Patients with initially depressed function, EF normalized in 21 of 22 patients (95.4%) (P value 0.000), but 5 of 22 (18.1%) of patients had persistently abnormal systolic strain at 3 months follow up (P value 0.817). Conclusion LV systolic dysfunction is common in the acute phase of MIS-C, and detection may be improved with global longitudinal strain assessment. Longitudinal cardiac follow-up is imperative, as patients may be at risk for persistent LV dysfunction.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1093/qjmed/hcae175.728
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.